Zivo Bioscience issues $150,000 10% promissory note to HEP Investments

Zivo Bioscience, Inc.

Principal amount $150,000; interest at 10% per annum; matures May 16, 2024.
Company has option to extend maturity date by an additional six months.
No prepayment penalty; note issued in private placement under Section 4(a)(2).
Subscriber HEP Investments, LLC is a significant shareholder of the Company.
Proceeds for general corporate purposes as determined by management.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Zivo Bioscience, Inc. entered into Subscription Agreement with HEP Investments, LLC valued at $150,000 (effective 2023-11-16).

Action: entry
Agreement: notes offering
Counterparty: HEP Investments, LLC
Value: $150,000
Effective: 2023-11-16

Exact text from the filing

On November 16, 2023, Zivo Bioscience, Inc. (the “ Company ”) entered into a Subscription Agreement (the “ Subscription Agreement ”) with the HEP Investments, LLC, a significant shareholder of the Company, (the “ Subscriber ”), pursuant to which the Company, in a private placement (the “ Private Placement ”), agreed to issue and sell to the Subscriber a 10% promissory note with a principal amount of $150,000 (the “ Note ”).

View on SEC.gov

Browse all material agreements →

Zivo Bioscience, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-23-014712

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.